TaiMed Biologics will present at Biologics CDMO Asia 2025, underscoring its proven track record in translating antibody R&D into scalable manufacturing.

📍 Presentation Details
Date & Time: September 11, 2025 (09:30)
Location: Sheraton Towers Singapore Hotel
Topic: “Advancing Antibody Therapeutics: Translating R&D to Scalable Commercial Manufacturing”

In this presentation, TaiMed will share key insights, including:
• The development of Trogarzo®, the world’s first FDA-approved HIV monoclonal antibody
• Lessons in bridging R&D, clinical development, and launch readiness
• How TaiMed leverages global CDMO partnerships and its own cGMP biologics facility to enable compliant and scalable manufacturing

With both internal and collaborative expertise, TaiMed is committed to supporting the delivery of innovative biologics to patients worldwide.
 
Back to the top